期刊文献+

甘露糖化脂质卷构建免疫细胞靶向疫苗佐剂-传递系统的研究

An immunocyte-targeting vaccine adjuvant-delivery system constituted with the mannosylated cochleates
下载PDF
导出
摘要 目的构建安全、稳定、免疫细胞靶向亚单位疫苗佐剂-传递系统。方法以磷脂酰丝氨酸为材料,采用乳化冻干法制备甘露糖修饰脂质卷,作为包封抗原载体。结果乳化冻干法制备脂质卷平均粒径为950 nm,呈杆状,对于模型抗原包封率为38%,能够保护抗原在室温条件下2周内结构完整,在37℃中性缓冲液中48 h抗原释放低于42%,并能够有效将所包封物质传递入免疫细胞。结论采用乳化-冻干法制备的脂质卷能够有效包封抗原,并提高其稳定性及免疫细胞靶向性,是一种有效的亚单位疫苗佐剂-传递系统。 Objective To establish a safe,stable and immunocyte-targeting subunit vaccine adjuvant-delivery system.Methods The mannose modified cochleates composed of phosphatidylserine(PS)were prepared through emulsification-lyophilization procedure for entrapping vaccine antigens.Results The prepared mannosylated cochleates(MC)had a rod-like shape,a size of around 950 nm and entrapment efficiencies for model antigen ovalbumin(OVA)of 38%.In vitro release test indicated that less than 42% of the associated OVA was liberated from the MC after 48 h incubation at 37 ℃ in a buffered neutral solution.Moreover,the MC maintained the antigens' integrity for 2 weeks at room temperature and could efficiently deliver the loaded antigens to immunocytes.Conclusions The MC prepared by emulsification-lyophilization procedure can efficiently entrap antigens,enhancing subunit vaccine stability and delivery of antigens to immunocytes,and thus could be an effective vaccine adjuvant-delivery system(APC).
出处 《安徽医药》 CAS 2016年第12期2248-2252,共5页 Anhui Medical and Pharmaceutical Journal
关键词 甘露糖基化 疫苗佐剂-传递系统 乳化-冻干法 脂质卷 免疫靶向 mannosylated cochleates vaccine adjuvant-delivery emulsification-lyophilization procedure cochleates immunocyte-target
  • 相关文献

参考文献2

二级参考文献33

  • 1Shi Y, Huang G. Recent developments of biodegradable and biocompatible materials based micro/nanoparticles for delivering nmcromolecular therapeutics[J]. Crit RevTherDrugCarrierSyst, 2009, 26(1): 29-84.
  • 2Mose O Oyewumi, Amit Kumar, Zheng C R. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses[J]. Expert RevVaccines, 2010, 9(9): 1095-1107.
  • 3ThambTi,ParkJH.RecentAdvancesinShell-SheddableNanopar-ticlesforCancerTherapy[J].JournalofBiomedicalNanotechnol-ogy,2014,10(9):1-22.
  • 4AkbarzadehA,Rezaei-SadabadyR,DavaranS,etal.Liposome:classification,preparation,andapplications[J].NanoscaleResLett,2013,8(1):102-111.
  • 5KraftJC,FreelingJP,WangZ,etal.EmergingResearchandClini-calDevelopmentTrendsofLiposomeandLipidNanoparticleDrugDeliverySystems[J].JPharmSci,2014,103(1):29-52.
  • 6PiJ,LiuZ,ShuL,etal.TissuedistributionstudyofsalvianolicacidBlong-circulatingliposomesinmicebyUPLC-MS/MSdeter-mination[J].PakJPharmSci,2015,28(1):213-220.
  • 7ShaviGV,ReddyMS,RaqhavendraR,etal.PEGylatedliposomesofanastrozoleforlong-termtreatmentofbreastcancer:invitroandinvivoevaluation[J].JLiposomeRes,2015[Epubaheadofprint].
  • 8ZhouJ,ZhaoWY,MaX,etal.Theanticancerefficacyofpaclitaxelliposomesmodifiedwithmitochondrialtargetingconjugateinresist-antlungcancer[J].Biomaterials,2013,34(14):3626-3638.
  • 9AbuLilaAS,NawataK,ShimizuT,etal.Useofpolyglycerol(PG),insteadofpolyethyleneglycol(PEG),preventsinductionoftheacceleratedbloodclearancephenomenonagainstlong-circu-latingliposomesuponrepeatedadministration[J].IntJPharm,2013,456(1):235-242.
  • 10YangQ,MaY,ZhaoY,etal.Accelerateddrugreleaseandclear-anceofPEGylatedepirubicinliposomesfollowingrepeatedinjec-tions:anewchallengeforsequentiallow-dosechemotherapy[J].IntJNanomedicine,2013,8:1257-1268.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部